SCHEMBL26873554

SCHEMBL26873554

C=CC(C)(C)c1cc(N)n2ncc(Cl)c2n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CCNA2 P20248 4/20 0.33
▸ CDK2 P24941 4/20 0.33
▸ CCNA1 P78396 4/20 0.33
▸ CCNT1 O60563 2/20 0.33
▸ CDK1 P06493 2/20 0.33
▸ CDK4 P11802 2/20 0.33
▸ CCND1 P24385 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26871218 0.86 KDM4E (0.34) KDM4EMAPTRAB9AALDH1A1CCNA2
SCHEMBL26869184 0.84 KDM4E (0.36) KDM4EMEN1NPC1MAPTRAB9A
SCHEMBL26873342 0.75 CDK2 (0.36) KDM4EMEN1NPC1MAPTRAB9A
SCHEMBL26873560 0.74 CDK9 (0.63) CYP1A2CCNA2CDK2CCNA1CCNT1
SCHEMBL26870979 0.73 KDM4E (0.36) KDM4EMEN1MAPTRAB9AKMT2A
SCHEMBL31465402 0.72 MAPT (0.61) KDM4EMEN1NPC1MAPTRAB9A
SCHEMBL26871243 0.72 KDM4E (0.33) KDM4EMAPTRAB9AALDH1A1
SCHEMBL23242923 0.72 MEN1 (0.42) KDM4EMEN1NPC1MAPTRAB9A
SCHEMBL26869183 0.71 KDM4E (0.40) KDM4ENPC1MAPTRAB9AALDH1A1
SCHEMBL31465464 0.70 KDM4E (0.41) KDM4EMEN1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 — — EP disclosed
Send feedback